Determination of the redox properties of human NADPH-cytochrome P450 reductase

被引:144
|
作者
Munro, AW
Noble, MA
Robledo, L
Daff, SN
Chapman, SK
机构
[1] Univ Strathclyde, Royal Coll, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland
[2] Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
关键词
D O I
10.1021/bi001718u
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Midpoint reduction potentials for the flavin cofactors in human NADPH-cytochrome P450 oxidoreductase were determined by anaerobic redox titration of the diflavin (FAD and FMN) enzyme and by separate titrations of its isolated FAD/NADPH and FMN domains. Flavin reduction potentials are similar in the isolated domains (FAD domain El [oxidized/semiquinone] = -286 +/- 6 mV, E-2 [semiquinone/ reduced] = -371 +/- 7 mV; FMN domain E-1 = -43 +/- 7 mV, E-2 = -280 +/- 8 mV) and the soluble diflavin reductase (E-1 [FMN] = -66 +/- 8 mV, E-2 [FMN] = -269 +/- 10 mV; E1 [FAD] = -283 +/- 5 mV, E2 [FAD] = -382 +/- 8 mV). The lack of perturbation of the individual flavin potentials in the FAD and FMN domains indicates that the flavins are located in discrete environments and that these environments are not significantly disrupted by genetic dissection of the domains. Each flavin titrates through a blue semiquinone state, with the FMN semiquinone being most intense due to larger separation (similar to 200 mV) of its two couples. Both the FMN domain and the soluble reductase are purified in partially reduced, colored form from the Escherichia coli expression system, either as a green reductase or a gray-blue FMN domain. In both cases, large amounts of the higher potential FMN are in the semiquinone form. The redox properties of human cytochrome P450 reductase (CPR) are similar to those reported for rabbit CPR and the reductase domain of neuronal nitric oxide synthase. However, they differ markedly from those of yeast and bacterial CPRs, pointing to an important evolutionary difference in electronic regulation of these enzymes.
引用
收藏
页码:1956 / 1963
页数:8
相关论文
共 50 条
  • [1] NADPH-CYTOCHROME P450 REDUCTASE
    MATSUBARA, T
    BARON, J
    PETERSON, LL
    PETERSON, JA
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1976, 172 (02) : 463 - 469
  • [2] Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase
    Guengerich, F. Peter
    Martin, Martha V.
    Sohl, Christal D.
    Cheng, Qian
    NATURE PROTOCOLS, 2009, 4 (09) : 1245 - 1251
  • [3] Crystallization studies of NADPH-cytochrome P450 reductase
    Kim, JJP
    Roberts, DL
    Djordjevic, S
    Wang, M
    Shea, TM
    Masters, BSS
    CYTOCHROME P450, PT B, 1996, 272 : 368 - 377
  • [4] An inducible NADPH-cytochrome P450 reductase from Picrorhiza kurrooa - an imperative redox partner of cytochrome P450 enzymes
    Bhat, Wajid Waheed
    Rana, Satiander
    Dhar, Niha
    Razdan, Sumeer
    Pandith, Shahzad A.
    Vishwakarma, Ram
    Lattoo, Surrinder K.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2014, 14 (02) : 381 - 399
  • [5] Engineering of proteolytically stable NADPH-cytochrome P450 reductase
    Bonina, TA
    Gilep, AA
    Estabrook, RW
    Usanov, SA
    BIOCHEMISTRY-MOSCOW, 2005, 70 (03) : 357 - 365
  • [6] ENZYMATIC PROPERTIES OF NADPH-CYTOCHROME P450 REDUCTASE FROM HOT PEPPER
    Joung, Young Hee
    Lee, Ga-Young
    Kim, Hyun Min
    Ma, Sang Hoon
    Park, Se Hee
    Yun, Chul-Ho
    DRUG METABOLISM REVIEWS, 2015, 47 : 71 - 72
  • [7] Engineering of proteolytically stable NADPH-cytochrome P450 reductase
    T. A. Bonina
    A. A. Gilep
    R. W. Estabrook
    S. A. Usanov
    Biochemistry (Moscow), 2005, 70 : 357 - 365
  • [8] Bioactivation of doxorubicin (DOX) by human NADPH-cytochrome p450 reductase (CYPRED).
    Ramji, S
    Inaba, T
    Riddick, DS
    FASEB JOURNAL, 1998, 12 (04): : A147 - A147
  • [9] Cytochrome P450 2S1 is Reduced by NADPH-Cytochrome P450 Reductase
    Xiao, Yi
    Shinkyo, Raku
    Guengerich, F. Peter
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (06) : 944 - 946
  • [10] Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase
    Guengerich, FP
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 440 (02) : 204 - 211